Drug Profile
EVP 1001-1
Alternative Names: EVP10011; SeeMoreLatest Information Update: 21 Dec 2015
Price :
$50
*
At a glance
- Originator Eagle Vision Pharmaceutical Corporation
- Class Cardiovascular therapies; Contrast media
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Myocardial infarction; Myocardial ischaemia
Most Recent Events
- 21 Dec 2015 No development reported - Phase-II for Myocardial infarction (Diagnosis) in USA (IV)
- 21 Dec 2015 No development reported - Phase-II for Myocardial ischaemia (Diagnosis) in USA (IV)